Some people who have systemic mastocytosis go on to develop mast cell leukaemia. Doctors don’t yet know the best way to treat either of these conditions. Midostaurin is a new drug that may slow down ...

Nature Reviews Rheumatology - Cytochrome P450 enzyme polymorphisms and treatment-related ovarian toxicity in patients with SLE Skip to main content Thank you for visiting nature.com.